Guideline: Institut National du Cancer Guidelines (France): Difference between revisions
m (Update categories.) |
m (Update categories.) |
||
| Line 84: | Line 84: | ||
<span style="display:none">hasCancerType::C69-C72: Eye and brain cancer</span> | <span style="display:none">hasCancerType::C69-C72: Eye and brain cancer</span> | ||
<span style="display:none">isPracticeGuideline</span> | <span style="display:none">isPracticeGuideline</span> | ||
<span style="display:none">hasCancerType::C00-D48: All neoplasms</span> | |||
<span style="display:none">hasCancerType::C00-C97: All cancer types</span> | |||
Revision as of 11:22, 6 December 2025
Go back to France page
Primary purpose: To define good practices and ensure the quality of care for cancer patients by producing and labeling national benchmarks and recommendations for healthcare professionals.
Sponsor, manager or home institution: Institut National du Cancer.
Type of information: Common good practices for the management of all cancers, pain and therapeutic management, diagnostics, treatments and care recommendations. Click here to learn more.
Cancer Areas of Interest: C30-C39: Lung/chest, cancers C50: Breast cancer, C51-C58: Female genitalia cancer, C43-C44: Skin cancers/melanoma, C15-C26: Digestive system cancers, C64-C68: Urinary system cancers, C81-C96: Cancers of the blood and immune system, C00-C14: Mouth/throat cancers, C69-C72: Eye and brain cancer. Click here to learn more
Access to information: Click here to access.